Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ: NVAX )

8.480 +0.440 (+5.47%)
Streaming Delayed Price Updated: 3:38 PM EST, Jan 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
60 61 Next >
What Are Whales Doing With Novavax
Someone with a lot of money to spend has taken a bullish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
Novavax Has Limited Pipeline Upside, Says BofA Analyst: What's Next?
Although Novavax, Inc’s (NASDAQ: NVAX) shares have tanked 59% year to date, there is still room for a further decline, according to BofA Securities. The Novavax Analyst: Alec Stranahan initiated... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022
Upgrades 
Via Benzinga
7 Growth Stocks to Avoid Until the Market Crashes Again
Not every investment idea offers a compelling discount. These growth stocks aren't what they once were. 
Via InvestorPlace
Avoid Novavax Stock as Its Hopes Dwindle
The FDA approval is the only hope for Novavax. If you own it, hold NVAX stock until the approval but do not take a new position right now. 
Via InvestorPlace
Why Novavax Stock Is Plunging Today
Novavax Inc (NASDAQ: NVAX) shares are trading lower Tuesday after the company reported worse-than-expected financial results. 
Via Benzinga
Novavax Crashes As Alternative To Pfizer, Moderna Covid Shots Lags Estimates
Novavax posted lighter-than-expected sales of its Covid shot, which doesn't use mRNA. 
Via Investor's Business Daily
3 Oversold Biotech Stocks to Buy Now
Looking for oversold biotech stocks? These three have all seen significant drops this year despite promising catalysts for the future. 
Via InvestorPlace
Biden Says US Ready To Share COVID-19 Vaccine Related Technology
Via Benzinga
White House Says Currently No Plans To Share COVID-19 Shots With North Korea Battling Outbreak
The Biden administration says it currently has no plans to share COVID-19 vaccines with North Korea, Reuters reported citing White House press secretary Jen Psaki. However, it supported providing aid... 
Via Benzinga
Cboe's Weekly Market Recap: May 2nd To May 6th
Photo by m. on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
99 Biggest Movers From Yesterday
Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company. 
Via Benzinga
52 Stocks Moving In Wednesday's Mid-Day Session
Gainers Trecora Resources (NYSE: TREC) shares jumped 26.6% to $9.56 as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247... 
Via Benzinga
Bausch Health (BHC) Stock Plunges 25% After Bausch + Lomb IPO
Bausch Health (BHC) stock is falling on Tuesday following the release of its earnings report for the first quarter of 2022. 
Via InvestorPlace
Why Moderna Shares Are Trading Lower Following Novavax's Earnings Report
Moderna Inc (NASDAQ: MRNA) shares are trading lower by 3.15% at $131.52. 
Via Benzinga
77 Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
PTON Stock Alert: 9 Things to Know as Peloton Plummets 15% After Reporting Earnings
Peloton (PTON) is the top trending stock on Yahoo today as the company's shares fall after releasing its fiscal Q3 2022 earnings report. 
Via InvestorPlace
NVAX Stock Falls 20% as Novavax Misses Q1 Estimates
The drug maker's stock is falling sharply on news that the company missed the profit and revenue expectations of analysts. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning! We're starting off another busy day of trading with a breakdown of the biggest pre-market stock movers for Tuesday! 
Via InvestorPlace
Novavax's 22% Post-Earnings Plunge: 5 Factors That Took Toll
Novavax, Inc. (NASDAQ: NVAX) shares slumped 22.27% after-hours on Monday, reacting to its quarterly financial report. 
Via Benzinga
30 Stocks Moving in Tuesday's Pre-Market Session
Gainers Vroom, Inc. (NASDAQ: VRM) shares rose 38% to $1.49 in pre-market trading after the company reported better-than-expected Q1 results. 
Via Benzinga
A Peek Into The Markets: US Stock Futures Higher Ahead Of Fed Speakers
Pre-open movers 
Via Benzinga
5 Stocks To Watch For May 10, 2022
Some of the stocks that may grab investor focus today are: 
Via Benzinga
Novavax Stock Is Too Sickly To Buy
Rivals pharmaceutical companies have beaten Novavax to market with a range of Covid-19 treatments, leaving NVAX stock in the dust. 
Via InvestorPlace
Check Out What Whales Are Doing With NVAX
Someone with a lot of money to spend has taken a bullish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
Why Novavax Shares Are Falling After Hours
Novavax Inc (NASDAQ: NVAX) shares are trading lower in Monday's after-hours session after the company reported worse-than-expected financial results. 
Via Benzinga
How Novavax Stock Looks Headed Into Q1 Earnings
Novavax, Inc. (NASDAQ: NVAX) is set to print its first-quarter financial results after the market close on Thursday. The stock was trading more than 6% lower, at one point, heading into the event. 
Via Benzinga
The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More
Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ:... 
Via Benzinga
Jim Cramer Shares His Thoughts On Chubb, Novavax And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes the long-term prospects of Plug Power Inc (NASDAQ: PLUG). "Right now, this is a very tough day for a stock like Plug Power," he added. 
Via Benzinga
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
60 61 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.